Pioneering the future of biologic medical solutions as an industry-leading biotechnology company focused on the development and commercialization of placental tissue and musculoskeletal-based implants. (Transitioning from white label to direct-to-consumer.)Reporting directly to the AVP, Western, this leadership role oversees a team of five Advanced Biologic Consultants across six states (Alaska, Washington, Oregon, Idaho, Montana, and Utah). The position requires hiring, developing, and managing this team while collaborating closely with channel partners, including PacWest, Elite Biologics, and SVP Medical, to drive revenue growth in the Pacific Northwest. Primary focus is targeting hospital systems, ambulatory surgical centers, and office-based practices in podiatry, dermatology, plastics, and mobile care. Emphasis on strategic client acquisition, cost reduction, and standardization across healthcare systems. Highlights include:- On target for achieving $MM revenue in 2025 through strategic client acquisition and contract negotiations with major healthcare systems, including PeaceHealth, St. Luke's Health System (Boise, ID), and SCA (200 ambulatory centers).- Collaborating with leading channel partners (i.e., PacWest, Elite Biologics, SVP Medical) to expand regional reach and align sales efforts with organizational goals.- Successfully hired and developed a high-performing sales team of 5 Advanced Biologic Consultants, driving results across a six-state territory.

Outset Medical is a pioneering medical technology company revolutionizing dialysis care with its Tablo® Hemodialysis System, and enterprise solution for Medical Centers, Dialysis Clinics and Home Care.Drove the adoption of Tablo across the PNW region (AK, WA, OR, ID, MT, WY). Disrupted the dialysis market by promoting and selling the Tablo Hemodialysis System and software platform. Utilized expertise in capital sales processes, building advocacy within healthcare facilities and executing strong solution-selling skills – with the tenacity to consistently meet sales objectives. Engaged strategically with all levels across healthcare organizations (i.e., Nephrologists, Medical Officers, C-Suite), by offering in-source solutions to challenges associated with outsourced dialysis. Highlights include:- Sourced and initiated contract negotiations with major healthcare organizations, including MultiCare, Providence, and Northwest Kidney Centers, driving strategic partnerships and revenue opportunities.- Designated as MVP of Advanced Sales Class, by developing clinical, financial, technical, and administrative support through in-depth industry knowledge and strategic customer engagement, identifying key institutions, generating market awareness, and presenting a compelling economic case for Tablo through a robust return on investment (ROI) analysis.- Facilitated product onboarding and provided comprehensive education on dialysis systems for staff at multiple dialysis centers, ensuring seamless integration and enhanced user proficiency.

Because no known viral transfer risk exists between North-Atlantic Cod and humans, the Kerecis patented fish skin is only gently processed and retains its similarity to human skin.Led and expanded sales channels and segments throughout the PNW region (AK, WA, OR, CA, NV, ID, UT, MT & WY). Recruited, developed, and managed the newly created team of 10 Business Development Managers, a Surgical Specialist, and multiple 1099 Sales Channel agents. Developed and implemented sales strategies to capture new accounts and nurture existing business. Sold and managed revenues consistent with company targets, by forging relationships with Key Opinion Leaders to promote Kerecis products in the market. Compiled and analyzed sales and market analytics, reporting to senior management. Highlights include:- Successfully achieved 127% to Quota for 2022 Fiscal Year within 8 months of hire.- Secured contracts with major Integrated Delivery Networks (IDNs), including Providence (entire IDN), St. Luke's (Boise), St. Alphonsus (Boise), and HCA Mountain Star (Salt Lake City), driving revenue growth and expanding market presence in the PNW region.- Sales targets included outpatient wound care centers of Hospitals/Medical Centers across the entirety of the Pacific Northwest, presenting the competitive uniqueness of fish skin vs. amniotic tissue and a lower price point - as compared to the competition. (i.e., Mimedx, Organogenesis, Smith and Nephew, MTF.)

COVID Sabbatical from the biotechnology industry. Created and developed Inside Sales and also directed Outside Sales teams across multiple sales verticals (OEM/Aftermarket Dealers/Online Sales) with $MM annualized revenue. Established profitable price structures and negotiated OEM distribution/dealer agreements. 30% YOY revenue growth and 10% YOY gross profit growth.

Hired, developed, and managed a team of 10 Account Executives throughout the Pacific Northwest (AK, WA, OR, ID, MT), representing both Surgical and Wound Care products. Highlights:- 110% to quota for 2019, $12M ARR (#2 in the Nation-Presidents Club Award)- 102% to quota for 2018, $8M ARR - 105% to quota for 2017, $4M ARR

Expanded the OR, ID and Eastern WA territory, promoting Epifix to Vascular surgeons, Plastic surgeons, Dermatologists, Orthopedic surgeons, General surgeons, and Podiatrists, including education and application of technology, pre-verification of patient insurance benefits, and reimbursement. Highlights:- 250% of quota for 2016, $2.5M ARR (#3 in the Nation-Presidents Club Award)- 200% of quota for 2015, $1.5M ARR (#17 in the Nation-President Club Award)- 100% of quota for 2014, $800K ARR

Musculoskeletal solutions

Dermagraft

Treatments for XLIF

PAD/Coronary Disease

Advanced wound care and Biologics